Internal Medicine, Infectious Disease · Mayaguez, PR
NPI
1275520900
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
0
Medicare group memberships
Hospitals
3
Hospital affiliations
Edif Centro Plaza Of4b, Mendez Vigo 63 E
Mayaguez, PR, 00680
Phone (787) 833-6270
Medicare paid, 2024
$5,759
77 services
Medicare patients, 2024
47
Average age 74
Drug cost, 2024
$562K
775 prescriptions
Company payments, 2025
$168
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ramon A Ramirez Ronda was code 99222 (hospital e&m - initial), 30 times for 27 patients. In total Ramon A Ramirez Ronda billed 77 services in 5 codes, and Medicare paid $5,759.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-11-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99222 Hospital E&M - Initial | Facility | 30 | 27 | $95.47 | $2,864 |
By year: 2022 $6,870 for 82 services; 2023 $6,381 for 77 services; 2024 $5,759 for 77 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ramon A Ramirez Ronda prescribed most often to Medicare patients was Valacyclovir (Valacyclovir Hcl), with 156 prescriptions and refills. In total Ramon A Ramirez Ronda wrote 775 Medicare prescriptions that cost $562K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Valacyclovir Valacyclovir Hcl | 156 | 156 | 28 | $5,620 |
| Acyclovir Generic | 145 | 150 | 85 | $2,795 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 29 | 29 | Under 11 | $108K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 22 | 22 | Under 11 | $88K |
| Famotidine Generic | 22 | 24 | Under 11 | $116 |
| Dovato Dolutegravir Sodium/Lamivudine | 19 | 19 | Under 11 | $56K |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 16 | 16 | Under 11 | $1,896 |
| Isentress Raltegravir Potassium | 12 | 12 | Under 11 | $24K |
| Prezcobix Darunavir/Cobicistat | 12 | 12 | Under 11 | $29K |
| Tivicay Dolutegravir Sodium | 12 | 12 | Under 11 | $27K |
| Descovy Emtricitabine/Tenofov Alafenam | 12 | 12 | Under 11 | $26K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 12 | 12 | 11 | $88.72 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 11 | 11 | Under 11 | $44K |
| Viracept Nelfinavir Mesylate | 11 | 11 | Under 11 | $13K |
| Gabapentin Generic | 11 | 13 | Under 11 | $130 |
Brand drugs: 187 claims; generic drugs: 588 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ramon A Ramirez Ronda $168 ($168 in general payments such as food, travel and fees) from 3 companies. The largest payer was Shionogi Inc with $123.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.